BMS 707035

BMS 707035 Uses, Dosage, Side Effects, Food Interaction and all others data.

BMS 707035 is under investigation in clinical trial NCT00397566 (A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects).

Trade Name BMS 707035
Generic HIV Integrase Inhibitor
HIV Integrase Inhibitor Other Names BMS 707035
Type
Formula C17H19FN4O5S
Weight Average: 410.42
Monoisotopic: 410.106019065
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
BMS 707035
BMS 707035

Innovators Monograph

You find simplified version here BMS 707035

*** Taking medicines without doctor's advice can cause long-term problems.
Share